Featured FDA Released

Jun 02, 2014
New FDA Release: PLA2R IFA [More]
Apr 14, 2014
EUROIMMUN IFA 40: HEp-20-10 [More]
Jul 31, 2013
New FDA Release: ANA Screen [More]

Welcome to EUROIMMUN US, Inc.

EUROIMMUN US, Inc., a subsidiary of EUROIMMUN, is a world leader in the field of medical diagnostics. EUROIMMUN established itself as an industry innovator with its unique IFA BIOCHIP Mosaic technology and has successfully introduced new technologies such as ELISA, Western & Immunoblot assays since its inception in 1987. The company’s global success is attributed to its strategic product development in which designer antigens, as well as patented and licensed technologies, play an important role. EUROIMMUN is consistently expanding its product offerings with new assays to aid in the detection of antibodies associated with autoimmune and infectious diseases. [More]

Upcoming Events

View all events

News of Interest

Jun 10, 2014
PLA2R Testing Locations [More]
Jun 02, 2014
New FDA Release: PLA2R IFA [More]
Mar 05, 2014
EUROBlotOne – Fully automated processing of immunoblot tests [More]
Mar 01, 2013
The Rise of Vitamin D Testing [More]
View all news of interest